Advertisement
UK markets open in 4 hours 5 minutes
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • HANG SENG

    17,566.67
    +282.13 (+1.63%)
     
  • CRUDE OIL

    83.76
    +0.19 (+0.23%)
     
  • GOLD FUTURES

    2,343.80
    +1.30 (+0.06%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,597.52
    +208.97 (+0.41%)
     
  • CMC Crypto 200

    1,390.99
    +8.41 (+0.61%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

A Look at SAGE Therapeutics’ Product Portfolio

A Look at SAGE Therapeutics’ Product Portfolio

SAGE Therapeutics (SAGE) includes two different programs based on the modulation of GABAA (gamma-Aminobutyric acid) and NMDA (N-methyl-D-aspartate) receptors for the treatment of life-threatening central nervous system disorders. Let’s have a look at the details of these programs.